| Year |
Citation |
Score |
| 2023 |
Rogers JP, Chou MKL, Pollak TA, Eyre M, Krutikov M, Church A, Hart MS, Karim A, Michael S, Vincent A, David AS, Lewis G, Jacob S, Zandi MS. Seasonal variation and temporal relationship to the COVID-19 pandemic of NMDA receptor antibody results. Journal of Neurology. PMID 37737893 DOI: 10.1007/s00415-023-11917-6 |
0.549 |
|
| 2022 |
Badenoch JB, Conti I, Rengasamy ER, Watson CJ, Butler M, Hussain Z, Carter B, Rooney AG, Zandi MS, Lewis G, David AS, Houlihan CF, Easton A, Michael BD, Kuppalli K, et al. Neurological and psychiatric presentations associated with human monkeypox virus infection: A systematic review and meta-analysis. Eclinicalmedicine. 101644. PMID 36246957 DOI: 10.1016/j.eclinm.2022.101644 |
0.557 |
|
| 2022 |
Saini A, Begum N, Matti J, Ghanem DA, Fripp L, Pollak TA, Zandi MS, David A, Lewis G, Rogers J. Clozapine as a treatment for catatonia: A systematic review. Schizophrenia Research. PMID 36117082 DOI: 10.1016/j.schres.2022.09.021 |
0.607 |
|
| 2022 |
Blackman G, Lim MF, Pollak T, Al-Diwani A, Symmonds M, Mazumder A, Carter B, Irani S, David A. The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data. Journal of Neurology. PMID 35790561 DOI: 10.1007/s00415-022-11224-6 |
0.596 |
|
| 2022 |
Jeyaventhan R, Thanikasalam R, Mehta MA, Solmi F, Pollak TA, Nicholson TR, Pritchard M, Jewell A, Kolliakou A, Amad A, Haroche A, Lewis G, Zandi MS, David AS, Rogers JP. Clinical Neuroimaging Findings in Catatonia: Neuroradiological Reports of MRI Scans of Psychiatric Inpatients With and Without Catatonia. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych210701. PMID 35414194 DOI: 10.1176/appi.neuropsych.21070181 |
0.6 |
|
| 2021 |
Rogers JP, Pollak TA, Begum N, Griffin A, Carter B, Pritchard M, Broadbent M, Kolliakou A, Ke J, Stewart R, Patel R, Bomford A, Amad A, Zandi MS, Lewis G, ... ... David AS, et al. Catatonia: demographic, clinical and laboratory associations. Psychological Medicine. 1-11. PMID 35135642 DOI: 10.1017/S0033291721004402 |
0.579 |
|
| 2021 |
Blackman G, Kumar K, Hanrahan JG, Dalrymple A, Mullatti N, Moran N, Valentin A, Gibson L, Pollak TA, David AS. Quantitative EEG as a Prognostic Tool in Suspected Anti-N-Methyl-D-Aspartate Receptor Antibody Encephalitis. Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society. PMID 34238869 DOI: 10.1097/WNP.0000000000000877 |
0.562 |
|
| 2021 |
Blackman G, Lisshammar JEL, Zafar R, Pollak TA, Pritchard M, Cullen AE, Rogers J, Carter B, Griffiths K, Nour M, David AS, McGuire P, Stewart R, MacCabe J. Clozapine Response in Schizophrenia and Hematological Changes. Journal of Clinical Psychopharmacology. 41: 19-24. PMID 33347018 DOI: 10.1097/JCP.0000000000001329 |
0.6 |
|
| 2020 |
Pollak TA, Vincent A, Iyegbe C, Coutinho E, Jacobson L, Rujescu D, Stone J, Jezequel J, Rogemond V, Jamain S, Groc L, David A, Egerton A, Kahn RS, Honnorat J, et al. Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis. Biological Psychiatry. PMID 33536130 DOI: 10.1016/j.biopsych.2020.11.014 |
0.59 |
|
| 2020 |
Pollak TA, Kempton MJ, Iyegbe C, Vincent A, Irani SR, Coutinho E, Menassa DA, Jacobson L, de Haan L, Ruhrmann S, Sachs G, Riecher-Rössler A, Krebs MO, Amminger P, Glenthøj B, ... ... David AS, et al. Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis. Molecular Psychiatry. PMID 33077853 DOI: 10.1038/s41380-020-00899-w |
0.608 |
|
| 2020 |
Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Psychiatric and neuropsychiatric syndromes and COVID-19 - Authors' reply. The Lancet. Psychiatry. 7: 664-665. PMID 32711701 DOI: 10.1016/S2215-0366(20)30304-7 |
0.578 |
|
| 2020 |
Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, Zandi MS, Lewis G, David AS. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The Lancet. Psychiatry. PMID 32437679 DOI: 10.1016/S2215-0366(20)30203-0 |
0.579 |
|
| 2020 |
Murray RM, Mondelli V, Stilo SA, Trotta A, Sideli L, Ajnakina O, Ferraro L, Vassos E, Iyegbe C, Schoeler T, Bhattacharyya S, Marques TR, Dazzan P, Lopez-Morinigo J, Colizzi M, ... ... David A, et al. The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study. Schizophrenia Research. PMID 32037203 DOI: 10.1016/J.Schres.2020.01.011 |
0.316 |
|
| 2020 |
Zammit S, Heron J, Rammos A, Jones H, Kounali D, Sullivan S, Croft J, Cannon M, David A, Fletcher P, Holmans P, Jones P, Linden D, Lewis G, Owen M, et al. S134. INCIDENCE, IMPACT AND TRAJECTORIES OF PSYCHOTIC EXPERIENCES FROM CHILDHOOD TO ADULTHOOD, AND PREDICTION OF PSYCHOTIC DISORDER Schizophrenia Bulletin. 46: S86-S86. DOI: 10.1093/Schbul/Sbaa031.200 |
0.334 |
|
| 2019 |
Rogers JP, Pollak TA, Blackman G, David AS. Catatonia and the immune system: a review. The Lancet. Psychiatry. PMID 31196793 DOI: 10.1016/S2215-0366(19)30190-7 |
0.576 |
|
| 2019 |
Townsend L, Johnson D, David A, Askey-Jones S, Brown R, Okai D. 26 Predictors of carer burden in impulse control disorders in parkinson’s disease Journal of Neurology, Neurosurgery, and Psychiatry. 90. DOI: 10.1136/Jnnp-2019-Bnpa.26 |
0.316 |
|
| 2018 |
Gibson LL, Pollak TA, Blackman G, Thornton M, Moran N, David AS. The Psychiatric Phenotype of Anti-NMDA Receptor Encephalitis. The Journal of Neuropsychiatry and Clinical Neurosciences. appineuropsych171203. PMID 30376787 DOI: 10.1176/appi.neuropsych.17120343 |
0.621 |
|
| 2018 |
Nettis MA, Pergola G, Kolliakou A, O'Connor J, Bonaccorso S, David A, Gaughran F, Di Forti M, Murray RM, Marques TR, Blasi G, Bertolino A, Pariante CM, Dazzan P, Mondelli V. Metabolic-inflammatory status as predictor of clinical outcome at 1-year follow-up in patients with first episode psychosis. Psychoneuroendocrinology. 99: 145-153. PMID 30243054 DOI: 10.1016/J.Psyneuen.2018.09.005 |
0.301 |
|
| 2018 |
Pollak TA, Rogers JP, Nagele RG, Peakman M, Stone JM, David AS, McGuire P. Antibodies in the Diagnosis, Prognosis, and Prediction of Psychotic Disorders. Schizophrenia Bulletin. PMID 29474698 DOI: 10.1093/Schbul/Sby021 |
0.596 |
|
| 2018 |
Reichenberg A, Zanelli J, Mollon J, Sandin S, Dazzan P, Morgan C, Pilecka I, Marques TR, Doody G, Morgan K, Fearon P, David A, Jones P, Murray R. O2.4. THE MISSING PIECE IN THE PUZZLE: COGNITIVE DECLINE IN SCHIZOPHRENIA AND BIPOLAR PATIENTS AFTER THE FIRST EPISODE Schizophrenia Bulletin. 44: S77-S77. DOI: 10.1093/Schbul/Sby015.194 |
0.317 |
|
| 2018 |
Mollon J, David A, Zammit S, Lewis G, Reichenberg A. 24.1 NEUROCOGNITIVE DEVELOPMENT FROM INFANCY TO EARLY ADULTHOOD IN THE PSYCHOSIS SPECTRUM Schizophrenia Bulletin. 44: S39-S39. DOI: 10.1093/Schbul/Sby014.096 |
0.333 |
|
| 2017 |
Pollak TA, Drndarski S, Stone JM, David AS, McGuire P, Abbott NJ. The blood-brain barrier in psychosis. The Lancet. Psychiatry. PMID 28781208 DOI: 10.1016/S2215-0366(17)30293-6 |
0.583 |
|
| 2017 |
Pollak T, Iyegbe C, Kempton M, Irani S, Stone J, Valmaggia L, Vincent A, David A, McGuire P. 15. Neuronal Autoantibodies and Blood-Brain Barrier Disruption in Subjects at Ultra-High Risk for Psychosis. Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx021.034 |
0.322 |
|
| 2016 |
Gilleen J, David A, Greenwood K. Self-reflection and set-shifting mediate awareness in cognitively preserved schizophrenia patients. Cognitive Neuropsychiatry. 1-12. PMID 27112316 DOI: 10.1080/13546805.2016.1167031 |
0.303 |
|
| 2016 |
Lemche E, Sierra-Siegert M, David AS, Phillips ML, Gasston D, Williams SC, Giampietro VP. Cognitive load and autonomic response patterns under negative priming demand in Depersonalisation-Derealisation Disorder. The European Journal of Neuroscience. PMID 26791018 DOI: 10.1111/Ejn.13183 |
0.427 |
|
| 2016 |
Pollak TA, Beck K, Irani SR, Howes OD, David AS, McGuire PK. Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications. Psychopharmacology. 233: 1605-21. PMID 26667479 DOI: 10.1007/S00213-015-4156-Y |
0.315 |
|
| 2015 |
Maayan N, Quraishi SN, David A, Jayaswal A, Eisenbruch M, Rathbone J, Asher R, Adams CE. Fluphenazine decanoate (depot) and enanthate for schizophrenia The Cochrane Database of Systematic Reviews. 2: CD000307. PMID 25654768 DOI: 10.1002/14651858.Cd000307.Pub2 |
0.325 |
|
| 2014 |
Kemp R, Russell G, David A. Shifting cerebral dominance in a woman with schizoaffective psychosis: a case study. Cognitive Neuropsychiatry. 2: 51-66. PMID 25420139 DOI: 10.1080/135468097396414 |
0.364 |
|
| 2014 |
Theleritis C, Fisher HL, Shäfer I, Winters L, Stahl D, Morgan C, Dazzan P, Breedvelt J, Sambath I, Vitoratou S, Russo M, Reichenberg A, Aurora Falcone M, Mondelli V, O'Connor J, ... David A, et al. Brain derived Neurotropic Factor (BDNF) is associated with childhood abuse but not cognitive domains in first episode psychosis. Schizophrenia Research. 159: 56-61. PMID 25171858 DOI: 10.1016/J.Schres.2014.07.013 |
0.309 |
|
| 2014 |
Dwyer K, David A, McCarthy R, McKenna P, Peters E. Higher-order semantic processing in formal thought disorder in schizophrenia. Psychiatry Research. 216: 168-76. PMID 24594202 DOI: 10.1016/J.Psychres.2014.02.011 |
0.351 |
|
| 2014 |
Dwyer K, Peters E, McKenna P, David A, McCarthy R. Verbatim recall in formal thought disorder in schizophrenia: a study of contextual influences. Cognitive Neuropsychiatry. 19: 337-58. PMID 24410090 DOI: 10.1080/13546805.2013.870069 |
0.359 |
|
| 2014 |
Pollak TA, Nicholson TR, Edwards MJ, David AS. A systematic review of transcranial magnetic stimulation in the treatment of functional (conversion) neurological symptoms. Journal of Neurology, Neurosurgery, and Psychiatry. 85: 191-7. PMID 23303960 DOI: 10.1136/jnnp-2012-304181 |
0.604 |
|
| 2013 |
Lemche E, Surguladze SA, Brammer MJ, Phillips ML, Sierra M, David AS, Williams SC, Giampietro VP. Dissociable brain correlates for depression, anxiety, dissociation, and somatization in depersonalization-derealization disorder. Cns Spectrums. 1-8. PMID 24059962 DOI: 10.1017/S1092852913000588 |
0.39 |
|
| 2013 |
Lemche E, Brammer MJ, David AS, Surguladze SA, Phillips ML, Sierra M, Williams SC, Giampietro VP. Interoceptive-reflective regions differentiate alexithymia traits in depersonalization disorder. Psychiatry Research. 214: 66-72. PMID 23932225 DOI: 10.1016/J.Pscychresns.2013.05.006 |
0.394 |
|
| 2013 |
Trotta A, Di Forti M, Mondelli V, Dazzan P, Pariante C, David A, Mulè A, Ferraro L, Formica I, Murray RM, Fisher HL. Prevalence of bullying victimisation amongst first-episode psychosis patients and unaffected controls. Schizophrenia Research. 150: 169-75. PMID 23891482 DOI: 10.1016/J.Schres.2013.07.001 |
0.332 |
|
| 2013 |
McCormack R, David A. INPATIENT TREATMENT OF SEVERE MOTOR CONVERSION DISORDER: A CASE-CONTROL STUDY Journal of Neurology, Neurosurgery & Psychiatry. 84: e1-e1. DOI: 10.1136/Jnnp-2013-306103.29 |
0.301 |
|
| 2012 |
Lemche E, Surguladze SA, Brammer MJ, Phillips ML, Sierra M, David AS, Williams SC, Giampietro VP. Multiple clinical traits predict clinical diagnosis of depersonalization disorder: implications for DSM-V. Biological Psychiatry. 72: e1-2. PMID 22206878 DOI: 10.1016/J.Biopsych.2011.12.003 |
0.381 |
|
| 2012 |
Gilleen J, Greenwood K, Archer N, Lovestone S, David AS. The role of premorbid personality and cognitive factors in awareness of illness, memory, and behavioural functioning in Alzheimer's disease. Cognitive Neuropsychiatry. 17: 227-45. PMID 21929281 DOI: 10.1080/13546805.2011.588007 |
0.301 |
|
| 2012 |
Nicholson T, Aybek S, Kempton M, David A, Kanaan R. P15 A structural MRI study of motor conversion disorder: evidence of bilateral reduction in thalamic volume Journal of Neurology, Neurosurgery & Psychiatry. 83: e1.26-e1. DOI: 10.1136/Jnnp-2012-303538.32 |
0.343 |
|
| 2011 |
López-Moríñigo JD, Ramos-Ríos R, David AS, Dutta R. Insight in schizophrenia and risk of suicide: a systematic update. Comprehensive Psychiatry. 53: 313-22. PMID 21821236 DOI: 10.1016/J.Comppsych.2011.05.015 |
0.322 |
|
| 2011 |
Campbell R, Capek CM, Gazarian K, MacSweeney M, Woll B, David AS, McGuire PK, Brammer MJ. The signer and the sign: cortical correlates of person identity and language processing from point-light displays. Neuropsychologia. 49: 3018-26. PMID 21767555 DOI: 10.1016/J.Neuropsychologia.2011.06.029 |
0.463 |
|
| 2011 |
Konstantakopoulos G, Tchanturia K, Surguladze SA, David AS. Insight in eating disorders: clinical and cognitive correlates. Psychological Medicine. 41: 1951-61. PMID 21211101 DOI: 10.1017/S0033291710002539 |
0.302 |
|
| 2011 |
Surguladze SA, Chu EM, Marshall N, Evans A, Anilkumar AP, Timehin C, McDonald C, Ecker C, Phillips ML, David AS. Emotion processing in schizophrenia: fMRI study of patients treated with risperidone long-acting injections or conventional depot medication. Journal of Psychopharmacology (Oxford, England). 25: 722-33. PMID 20360158 DOI: 10.1177/0269881110363316 |
0.437 |
|
| 2010 |
Shotbolt P, Samuel M, David A. Quetiapine in the treatment of psychosis in Parkinson’s disease Therapeutic Advances in Neurological Disorders. 3: 339-350. PMID 21179595 DOI: 10.1177/1756285610389656 |
0.305 |
|
| 2010 |
Gilleen J, Greenwood K, David AS. Domains of awareness in schizophrenia. Schizophrenia Bulletin. 37: 61-72. PMID 20851850 DOI: 10.1093/Schbul/Sbq100 |
0.353 |
|
| 2010 |
Capek CM, Woll B, MacSweeney M, Waters D, McGuire PK, David AS, Brammer MJ, Campbell R. Superior temporal activation as a function of linguistic knowledge: insights from deaf native signers who speechread. Brain and Language. 112: 129-34. PMID 20042233 DOI: 10.1016/J.Bandl.2009.10.004 |
0.439 |
|
| 2010 |
Radua J, Phillips ML, Russell T, Lawrence N, Marshall N, Kalidindi S, El-Hage W, McDonald C, Giampietro V, Brammer MJ, David AS, Surguladze SA. Neural response to specific components of fearful faces in healthy and schizophrenic adults. Neuroimage. 49: 939-46. PMID 19699306 DOI: 10.1016/J.Neuroimage.2009.08.030 |
0.659 |
|
| 2009 |
Patel M, Zoysa ND, Bernadt M, David A. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing. Journal of Psychopharmacology. 23: 789-796. PMID 18583438 DOI: 10.1177/0269881108092124 |
0.301 |
|
| 2009 |
Phillips ML, Howard R, David AS. "Mirror, mirror on the wall, who...?": towards a model of visual self-recognition. Cognitive Neuropsychiatry. 1: 153-64. PMID 16571480 DOI: 10.1080/135468096396613 |
0.365 |
|
| 2009 |
Wiffen B, David A. Metacognition, mindreading, and insight in schizophrenia Behavioral and Brain Sciences. 32: 161-162. DOI: 10.1017/S0140525X09000806 |
0.346 |
|
| 2008 |
Waters D, Campbell R, Capek CM, Woll B, David AS, McGuire PK, Brammer MJ, MacSweeney M. Corrigendum to "Fingerspelling, signed language, text and picture processing in deaf native signers: The role of the mid-fusiform gyrus" [NeuroImage 35 (2007) 1287-1302]. Neuroimage. 40: 984-986. PMID 28916362 DOI: 10.1016/J.Neuroimage.2007.12.023 |
0.419 |
|
| 2008 |
Brébion G, David AS, Bressan RA, Ohlsen RI, Pilowsky LS. Hallucinations and two types of free-recall intrusion in schizophrenia. Psychological Medicine. 39: 917-26. PMID 19079808 DOI: 10.1017/S0033291708004819 |
0.321 |
|
| 2008 |
Capek CM, Waters D, Woll B, MacSweeney M, Brammer MJ, McGuire PK, David AS, Campbell R. Hand and mouth: cortical correlates of lexical processing in British Sign Language and speechreading English. Journal of Cognitive Neuroscience. 20: 1220-34. PMID 18284353 DOI: 10.1162/Jocn.2008.20084 |
0.444 |
|
| 2008 |
Capek CM, Macsweeney M, Woll B, Waters D, McGuire PK, David AS, Brammer MJ, Campbell R. Cortical circuits for silent speechreading in deaf and hearing people. Neuropsychologia. 46: 1233-41. PMID 18249420 DOI: 10.1016/J.Neuropsychologia.2007.11.026 |
0.453 |
|
| 2008 |
Reichenberg A, Caspi A, Glahn D, Weiser M, Lubin G, Kravitz E, Rabinowitz J, David A, Murray R, Davidson M. Premorbid Intellectual Functioning And Social Adjustment And Risk Of Developing Schizophrenia, Psychotic Or Non-Psychotic Bipolar Disorder: A Population Longitudinal Study Schizophrenia Research. 102: 168-169. DOI: 10.1016/S0920-9964(08)70514-0 |
0.331 |
|
| 2008 |
Bedford N, David A. Ineffective Self-Reflection In Schizophrenia Relates To Denial Of Illness: Evidence Using A Levels Of Processing Mnemonic Paradigm Schizophrenia Research. 102: 116. DOI: 10.1016/S0920-9964(08)70352-9 |
0.309 |
|
| 2008 |
David A. Poor Insight In Schizophrenia: Lack Of Awareness Or Denial? Schizophrenia Research. 102: 28-29. DOI: 10.1016/S0920-9964(08)70090-2 |
0.313 |
|
| 2007 |
Morgan KD, Dazzan P, Orr KG, Hutchinson G, Chitnis X, Suckling J, Lythgoe D, Pollock SJ, Rossell S, Shapleske J, Fearon P, Morgan C, David A, McGuire PK, Jones PB, et al. Grey matter abnormalities in first-episode schizophrenia and affective psychosis. The British Journal of Psychiatry. Supplement. 51: s111-6. PMID 18055926 DOI: 10.1192/Bjp.191.51.S111 |
0.352 |
|
| 2007 |
Shad MU, Keshavan MS, Tamminga CA, Cullum CM, David A. Neurobiological underpinnings of insight deficits in schizophrenia. International Review of Psychiatry (Abingdon, England). 19: 437-46. PMID 17671876 DOI: 10.1080/09540260701486324 |
0.36 |
|
| 2007 |
Lemche E, Surguladze SA, Giampietro VP, Anilkumar A, Brammer MJ, Sierra M, Chitnis X, Williams SC, Gasston D, Joraschky P, David AS, Phillips ML. Limbic and prefrontal responses to facial emotion expressions in depersonalization. Neuroreport. 18: 473-7. PMID 17496806 DOI: 10.1097/Wnr.0B013E328057Deb3 |
0.411 |
|
| 2007 |
Baiano M, David A, Versace A, Churchill R, Balestrieri M, Brambilla P. Anterior cingulate volumes in schizophrenia: a systematic review and a meta-analysis of MRI studies. Schizophrenia Research. 93: 1-12. PMID 17399954 DOI: 10.1016/J.Schres.2007.02.012 |
0.343 |
|
| 2007 |
Waters D, Campbell R, Capek CM, Woll B, David AS, McGuire PK, Brammer MJ, MacSweeney M. Fingerspelling, signed language, text and picture processing in deaf native signers: the role of the mid-fusiform gyrus. Neuroimage. 35: 1287-302. PMID 17363278 DOI: 10.1016/J.Neuroimage.2007.01.025 |
0.442 |
|
| 2007 |
Abhijnhan A, Adams CE, David A, Ozbilen M. Depot fluspirilene for schizophrenia Cochrane Database of Systematic Reviews. CD001718. PMID 17253464 DOI: 10.1002/14651858.Cd001718.Pub2 |
0.322 |
|
| 2007 |
David A. Robert William Kerwin Bmj. 334: 1170-1170. DOI: 10.1136/Bmj.39224.555486.Be |
0.312 |
|
| 2007 |
Baker D, Earle M, Medford N, Sierra M, Towell A, David A. Illness perceptions in depersonalization disorder: Testing and illness attribution model Clinical Psychology and Psychotherapy. 14: 105-116. DOI: 10.1002/Cpp.518 |
0.345 |
|
| 2006 |
Medford N, Brierley B, Brammer M, Bullmore ET, David AS, Phillips ML. Emotional memory in depersonalization disorder: a functional MRI study. Psychiatry Research. 148: 93-102. PMID 17085021 DOI: 10.1016/J.Pscychresns.2006.05.007 |
0.389 |
|
| 2006 |
Sierra M, Senior C, Phillips ML, David AS. Autonomic response in the perception of disgust and happiness in depersonalization disorder. Psychiatry Research. 145: 225-31. PMID 17074399 DOI: 10.1016/J.Psychres.2005.05.022 |
0.42 |
|
| 2006 |
Sierra M, Baker D, Medford N, Lawrence E, Patel M, Phillips ML, David AS. Lamotrigine as an add-on treatment for depersonalization disorder: a retrospective study of 32 cases. Clinical Neuropharmacology. 29: 253-8. PMID 16960469 DOI: 10.1097/01.Wnf.0000228368.17970.Da |
0.402 |
|
| 2006 |
Surguladze S, Russell T, Kucharska-Pietura K, Travis MJ, Giampietro V, David AS, Phillips ML. A reversal of the normal pattern of parahippocampal response to neutral and fearful faces is associated with reality distortion in schizophrenia. Biological Psychiatry. 60: 423-31. PMID 16487943 DOI: 10.1016/J.Biopsych.2005.11.021 |
0.453 |
|
| 2006 |
MacSweeney M, Campbell R, Woll B, Brammer MJ, Giampietro V, David AS, Calvert GA, McGuire PK. Lexical and sentential processing in British Sign Language. Human Brain Mapping. 27: 63-76. PMID 15966001 DOI: 10.1002/Hbm.20167 |
0.454 |
|
| 2006 |
Baiano M, David A, Versace A, Churchill R, Balestrieri M, Brambilla P. P.1.b.002 Anterior cingulate volumes in schizophrenia: a systematic research review and a meta-analysis of MRI studies European Neuropsychopharmacology. 16. DOI: 10.1016/S0924-977X(06)70157-2 |
0.301 |
|
| 2005 |
Kucharska-Pietura K, David AS, Masiak M, Phillips ML. Perception of facial and vocal affect by people with schizophrenia in early and late stages of illness. The British Journal of Psychiatry : the Journal of Mental Science. 187: 523-8. PMID 16319404 DOI: 10.1192/Bjp.187.6.523 |
0.449 |
|
| 2005 |
Saravanan B, David A, Bhugra D, Prince M, Jacob KS. Insight in people with psychosis: The influence of culture International Review of Psychiatry. 17: 83-87. PMID 16194776 DOI: 10.1080/09540260500073596 |
0.315 |
|
| 2005 |
Hunter EC, Baker D, Phillips ML, Sierra M, David AS. Cognitive-behaviour therapy for depersonalisation disorder: an open study. Behaviour Research and Therapy. 43: 1121-30. PMID 16005701 DOI: 10.1016/J.Brat.2004.08.003 |
0.445 |
|
| 2005 |
Medford N, Phillips ML, Brierley B, Brammer M, Bullmore ET, David AS. Emotional memory: separating content and context. Psychiatry Research. 138: 247-58. PMID 15854792 DOI: 10.1016/J.Pscychresns.2004.10.004 |
0.394 |
|
| 2005 |
David AS, Prince M. Psychosis following head injury: a critical review. Journal of Neurology, Neurosurgery, and Psychiatry. i53-60. PMID 15718223 DOI: 10.1136/Jnnp.2004.060475 |
0.32 |
|
| 2005 |
Lemche E, Surguladze S, Giampietro V, Brammer M, Kumar A, David A, Joraschky P, Phillips M. Segregable loci of orbitofrontal trigger regions for emotion release following happy and sad facial expression stimulation in ER-fMRI - fMRI-online psychophysiology and BOLD signal time series extraction in depersonalization patients and normal volunteers Ppmp - Psychotherapie · Psychosomatik · Medizinische Psychologie. 55. DOI: 10.1055/S-2005-863395 |
0.468 |
|
| 2004 |
MacSweeney M, Campbell R, Woll B, Giampietro V, David AS, McGuire PK, Calvert GA, Brammer MJ. Dissociating linguistic and nonlinguistic gestural communication in the brain. Neuroimage. 22: 1605-18. PMID 15275917 DOI: 10.1016/J.Neuroimage.2004.03.015 |
0.458 |
|
| 2004 |
Shaw P, Mellers J, Henderson M, Polkey C, David AS, Toone BK. Schizophrenia-like psychosis arising de novo following a temporal lobectomy: timing and risk factors. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 1003-8. PMID 15201360 DOI: 10.1136/Jnnp.2003.022392 |
0.329 |
|
| 2004 |
Shaw P, Lawrence EJ, Radbourne C, Bramham J, Polkey CE, David AS. The impact of early and late damage to the human amygdala on 'theory of mind' reasoning Brain. 127: 1535-1548. PMID 15155523 DOI: 10.1093/Brain/Awh168 |
0.304 |
|
| 2004 |
Williams LM, Das P, Harris AW, Liddell BB, Brammer MJ, Olivieri G, Skerrett D, Phillips ML, David AS, Peduto A, Gordon E. Dysregulation of arousal and amygdala-prefrontal systems in paranoid schizophrenia. The American Journal of Psychiatry. 161: 480-9. PMID 14992974 DOI: 10.1176/Appi.Ajp.161.3.480 |
0.455 |
|
| 2004 |
Hunter EC, Phillips ML, Chalder T, Sierra M, David AS. Depersonalisation disorder: a cognitive-behavioural conceptualisation. Behaviour Research and Therapy. 41: 1451-67. PMID 14583413 DOI: 10.1016/S0005-7967(03)00066-4 |
0.442 |
|
| 2004 |
Rossell S, David A, Coltheart M. Are semantic processing deficits in schizophrenia an access or storage problem Schizophrenia Research. 67: 12-12. DOI: 10.1016/J.Schres.2003.10.001 |
0.301 |
|
| 2003 |
Medford N, Baker D, Hunter E, Sierra M, Lawrence E, Phillips ML, David AS. Chronic depersonalization following illicit drug use: a controlled analysis of 40 cases. Addiction (Abingdon, England). 98: 1731-6. PMID 14651505 DOI: 10.1111/J.1360-0443.2003.00548.X |
0.38 |
|
| 2003 |
Baker D, Hunter E, Lawrence E, Medford N, Patel M, Senior C, Sierra M, Lambert MV, Phillips ML, David AS. Depersonalisation disorder: clinical features of 204 cases. The British Journal of Psychiatry : the Journal of Mental Science. 182: 428-33. PMID 12724246 DOI: 10.1192/Bjp.182.5.428 |
0.403 |
|
| 2003 |
Sierra M, Phillips ML, Ivin G, Krystal J, David AS. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. Journal of Psychopharmacology (Oxford, England). 17: 103-5. PMID 12680746 DOI: 10.1177/0269881103017001712 |
0.416 |
|
| 2003 |
Kucharska-Pietura K, Phillips ML, Gernand W, David AS. Perception of emotions from faces and voices following unilateral brain damage. Neuropsychologia. 41: 1082-90. PMID 12667543 DOI: 10.1016/S0028-3932(02)00294-4 |
0.4 |
|
| 2003 |
Abel KM, Allin MP, Kucharska-Pietura K, David A, Andrew C, Williams S, Brammer MJ, Phillips ML. Ketamine alters neural processing of facial emotion recognition in healthy men: an fMRI study. Neuroreport. 14: 387-91. PMID 12634489 DOI: 10.1097/01.Wnr.0000058031.29600.31 |
0.493 |
|
| 2003 |
Rossell SL, Coakes J, Shapleske J, Woodruff PW, David AS. Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychological Medicine. 33: 111-9. PMID 12537042 DOI: 10.1017/S0033291702006803 |
0.345 |
|
| 2003 |
Patel MX, Nikolaou V, David AS. Psychiatrists' attitudes to maintenance medication for patients with schizophrenia. Psychological Medicine. 33: 83-9. PMID 12537039 DOI: 10.1017/S0033291702006797 |
0.32 |
|
| 2003 |
Abel KM, Allin MP, Kucharska-Pietura K, Andrew C, Williams S, David AS, Phillips ML. Ketamine and fMRI BOLD signal: distinguishing between effects mediated by change in blood flow versus change in cognitive state. Human Brain Mapping. 18: 135-45. PMID 12518293 DOI: 10.1002/Hbm.10064 |
0.375 |
|
| 2003 |
Baker D, Hunter E, Lawrence E, Medford N, Patel M, Senior C, Sierra M, Lambert MV, Phillips ML, David AS. Depersonalisation disorder: clinical features of 204 cases British Journal of Psychiatry. 182: 428-433. DOI: 10.1192/bjp.182.5.428 |
0.44 |
|
| 2003 |
MacCabe J, Rossell S, Chitnis X, David A, Murray R. Cognitive decline is associated with reduction in global white matter volume in schizophrenia Schizophrenia Research. 60: 144-145. DOI: 10.1016/S0920-9964(03)80957-X |
0.305 |
|
| 2002 |
MacSweeney M, Woll B, Campbell R, Calvert GA, McGuire PK, David AS, Simmons A, Brammer MJ. Neural correlates of British sign language comprehension: spatial processing demands of topographic language. Journal of Cognitive Neuroscience. 14: 1064-75. PMID 12419129 DOI: 10.1162/089892902320474517 |
0.445 |
|
| 2002 |
Sierra M, Senior C, Dalton J, McDonough M, Bond A, Phillips ML, O'Dwyer AM, David AS. Autonomic response in depersonalization disorder. Archives of General Psychiatry. 59: 833-8. PMID 12215083 DOI: 10.1001/Archpsyc.59.9.833 |
0.41 |
|
| 2002 |
MacSweeney M, Woll B, Campbell R, McGuire PK, David AS, Williams SC, Suckling J, Calvert GA, Brammer MJ. Neural systems underlying British Sign Language and audio-visual English processing in native users. Brain : a Journal of Neurology. 125: 1583-93. PMID 12077007 DOI: 10.1093/Brain/Awf153 |
0.446 |
|
| 2002 |
Lambert MV, Sierra M, Phillips ML, David AS. The spectrum of organic depersonalization: a review plus four new cases. The Journal of Neuropsychiatry and Clinical Neurosciences. 14: 141-54. PMID 11983788 DOI: 10.1176/Jnp.14.2.141 |
0.423 |
|
| 2002 |
Knapp M, Ilson S, David A. Depot antipsychotic preparations in schizophrenia: the state of the economic evidence. International Clinical Psychopharmacology. 17: 135-140. PMID 11981355 DOI: 10.1097/00004850-200205000-00007 |
0.303 |
|
| 2002 |
MacSweeney M, Calvert GA, Campbell R, McGuire PK, David AS, Williams SC, Woll B, Brammer MJ. Speechreading circuits in people born deaf. Neuropsychologia. 40: 801-7. PMID 11900730 DOI: 10.1016/S0028-3932(01)00180-4 |
0.459 |
|
| 2001 |
Stanton BR, David AS, Cleare AJ, Sierra M, Lambert MV, Phillips ML, Porter RJ, Gallagher P, Young AH. Basal activity of the hypothalamic-pituitary-adrenal axis in patients with depersonalization disorder. Psychiatry Research. 104: 85-9. PMID 11600192 DOI: 10.1016/S0165-1781(01)00291-8 |
0.409 |
|
| 2001 |
Phillips ML, Sierra M, Hunter E, Lambert MV, Medford N, Senior C, David AS. Service innovations: a depersonalisation research unit progress report Psychiatric Bulletin. 25: 105-108. DOI: 10.1192/Pb.25.3.105 |
0.406 |
|
| 2001 |
MacSweeney M, Woll B, Brammer M, Campbell R, Calvert G, David A, Williams SC, McGuire PK. Cortical correlates of lexical and syntactic sign language processing Neuroimage. 13: 563. DOI: 10.1016/S1053-8119(01)91906-8 |
0.479 |
|
| 2000 |
Quraishi SN, David A. Depot pipothiazine palmitate and undeclynate for schizophrenia Cochrane Database of Systematic Reviews. CD001720. PMID 11686995 DOI: 10.1002/14651858.Cd001720 |
0.328 |
|
| 2000 |
Brébion G, Amador X, David A, Malaspina D, Sharif Z, Gorman JM. Positive symptomatology and source-monitoring failure in schizophrenia - An analysis of symptom-specific effects Psychiatry Research. 95: 119-131. PMID 10963798 DOI: 10.1016/S0165-1781(00)00174-8 |
0.349 |
|
| 2000 |
Kuperberg GR, McGuire PK, David AS. Sensitivity to linguistic anomalies in spoken sentences: a case study approach to understanding thought disorder in schizophrenia. Psychological Medicine. 30: 345-57. PMID 10824655 DOI: 10.1017/S0033291700001744 |
0.356 |
|
| 2000 |
Critchley H, Daly E, Phillips M, Brammer M, Bullmore E, Williams S, Van Amelsvoort T, Robertson D, David A, Murphy D. Explicit and implicit neural mechanisms for processing of social information from facial expressions: a functional magnetic resonance imaging study. Human Brain Mapping. 9: 93-105. PMID 10680766 DOI: 10.1002/(Sici)1097-0193(200002)9:2<93::Aid-Hbm4>3.0.Co;2-Z |
0.46 |
|
| 2000 |
David A. Cerebral dysfunction after water pollution incident in Camelford. Results were biased by self selection of cases. Bmj. 320: 1337-1337. DOI: 10.1136/Bmj.320.7245.1337 |
0.304 |
|
| 2000 |
MacSweeney M, Campbell R, Calvert G, McGuire P, David A, Suckling J, Woll BL, Brammer MJ. Activation of lateral temporal cortex during speechreading in deaf people Neuroimage. 11: S319. DOI: 10.1016/S1053-8119(00)91251-5 |
0.494 |
|
| 2000 |
Quraishi S, Adams C, Fenton M, Continho E, Roberts L, David A. A systematic review of all depot neuroleptics in the treatment of people with schizophrenia Schizophrenia Research. 41: 215-215. DOI: 10.1016/S0920-9964(00)90837-5 |
0.307 |
|
| 2000 |
Surguladze S, Rossell S, Rabe-Hesketh S, Campbell R, David A. Greater priming across modalities in schizophrenia: Evidence for abnormal semantics? Schizophrenia Research. 41: 16-17. DOI: 10.1016/S0920-9964(00)90340-2 |
0.322 |
|
| 2000 |
Phillips M, Williams L, Senior C, Bullmore E, Brammer M, Andrew C, Williams S, David A. Increased right amygdala activation to fear in paranoid schizophrenics: An FMRI study Schizophrenia Research. 41: 12. DOI: 10.1016/S0920-9964(00)90332-3 |
0.443 |
|
| 2000 |
Phillips M, Medford N, Senior C, Bullmore E, Brammer M, Andrew C, Sierra M, Williams S, David A. 313. Depersonalization disorder: neural correlates of thinking without feeling Biological Psychiatry. 47: S94-S95. DOI: 10.1016/S0006-3223(00)00577-1 |
0.462 |
|
| 1999 |
David A, Adams CE, Quraishi SN. Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders. Cochrane Database of Systematic Reviews. CD001470. PMID 10796442 DOI: 10.1002/14651858.Cd001470 |
0.335 |
|
| 1999 |
Quraishi SN, David A, Brasil MA, Alheira FV. Depot haloperidol decanoate for schizophrenia. Cochrane Database of Systematic Reviews. 1999. PMID 10796438 DOI: 10.1002/14651858.Cd001361 |
0.341 |
|
| 1999 |
Senior C, Barnes J, Jenkins R, Landau S, Phillips M, David A. ATTRIBUTION OF SOCIAL DOMINANCE AND MALENESS TO SCHEMATIC FACES Social Behavior and Personality: An International Journal. 27: 331-337. DOI: 10.2224/Sbp.1999.27.4.331 |
0.435 |
|
| 1999 |
Surguladze S, David A. Insight and Major Mental Illness: An Update for Clinicians Advances in Psychiatric Treatment. 5: 163-170. DOI: 10.1192/Apt.5.3.163 |
0.304 |
|
| 1998 |
Malmberg A, Lewis G, David A, Allebeck P. Premorbid adjustment and personality in people with schizophrenia. The British Journal of Psychiatry : the Journal of Mental Science. 172: 308-13; discussion 3. PMID 9715332 DOI: 10.1192/Bjp.172.4.308 |
0.321 |
|
| 1998 |
Lambert MV, David A. The importance of mental fatigue Journal of Neurology, Neurosurgery, and Psychiatry. 64: 430-430. PMID 9576530 DOI: 10.1136/Jnnp.64.4.430 |
0.314 |
|
| 1998 |
Critchley H, Daly E, Phillips M, Brammer M, Williams S, Van Amelsvoort T, Robertson D, David A, Murphy D. Dissociation of implicit and explicit neural mechanisms for processing of emotional facial expressions: A model for investigating developmental disorders of social behavior Neuroimage. 7: S905. DOI: 10.1016/S1053-8119(18)31738-5 |
0.458 |
|
| 1997 |
Phillips ML, Howard R, David AS. A cognitive neuropsychological approach to the study of delusions in late-onset schizophrenia. International Journal of Geriatric Psychiatry. 12: 892-901. PMID 9309466 DOI: 10.1002/(SICI)1099-1166(199709)12:9<892::AID-GPS657>3.0.CO;2-0 |
0.427 |
|
| 1997 |
Kemp R, David A. Psychological predictors of insight and compliance in psychotic patients. The British Journal of Psychiatry : the Journal of Mental Science. 169: 444-50. PMID 8894195 DOI: 10.1192/Bjp.169.4.444 |
0.314 |
|
| 1996 |
Woodruff P, David A, Howard R, Mellers J, Brammer M, Bullmore E, Wright I, Barker G, Williams S. Neural correlates of the experience of auditory hallucinations in schizophrenia Schizophrenia Research. 18: 196. DOI: 10.1016/0920-9964(96)85614-3 |
0.305 |
|
| 1995 |
David A, Minne C, Jones P, Harvey I, Ron M. Structure and function of the corpus callosum in schizophrenia: What's the connection? European Psychiatry : the Journal of the Association of European Psychiatrists. 10: 28-35. PMID 19698312 DOI: 10.1016/0767-399X(96)80072-1 |
0.307 |
|
| 1995 |
David A, van Os J, Jones P, Harvey I, Foerster A, Fahy T. Insight and psychotic illness. Cross-sectional and longitudinal associations. The British Journal of Psychiatry : the Journal of Mental Science. 167: 621-8. PMID 8564318 DOI: 10.1192/Bjp.167.5.621 |
0.355 |
|
| 1995 |
Phillips ML, David AS. Understanding the symptoms of schizophrenia using visual scan paths. The British Journal of Psychiatry : the Journal of Mental Science. 165: 673-5. PMID 7866684 DOI: 10.1192/Bjp.165.5.673 |
0.415 |
|
| 1995 |
David A, Malmberg A, Lewis G, Brandt L, Allebeck P. Are there neurological and sensory risk factors for schizophrenia? Schizophrenia Research. 14: 247-51. PMID 7766536 DOI: 10.1016/0920-9964(94)00068-J |
0.336 |
|
| 1995 |
Krasucki C, Kemp R, David A. A case study of female genital self-mutilation in schizophrenia. The British Journal of Medical Psychology. 179-86. PMID 7547614 DOI: 10.1111/J.2044-8341.1995.Tb01824.X |
0.31 |
|
| 1995 |
Kemp R, David A. Psychosis Current Opinion in Psychiatry. 8: 357-361. DOI: 10.1097/00001504-199511000-00002 |
0.327 |
|
| 1992 |
David A, Buchanan A, Reed A, Almeida O. The assessment of insight in psychosis. The British Journal of Psychiatry : the Journal of Mental Science. 161: 599-602. PMID 1422606 DOI: 10.1192/Bjp.161.5.599 |
0.303 |
|
| 1992 |
Lewis G, David A, Andréasson S, Allebeck P. Schizophrenia and city life. Lancet (London, England). 340: 137-40. PMID 1352565 DOI: 10.1016/0140-6736(92)93213-7 |
0.334 |
|
| 1990 |
Lewis G, Croft-Jeffreys C, David A. Are British psychiatrists racist British Journal of Psychiatry. 157: 410-415. PMID 2245273 DOI: 10.1192/Bjp.157.3.410 |
0.316 |
|
| Show low-probability matches. |